TY - JOUR
T1 - Characterization of a transient unfolding intermediate in a core mutant of γs-Crystallin
AU - Mahler, Bryon
AU - Doddapaneni, Kiran
AU - Kleckner, Ian
AU - Yuan, Chunhua
AU - Wistow, Graeme
AU - Wu, Zhengrong
N1 - Funding Information:
We are very grateful for useful discussion with Dr Lewis Kay and the software support from his laboratory. Z.W. is funded by NIH R21EY018423 , G.W. is funded by the NEI intramural program, and I.K. is supported by NIH R016M077234 (for Dr Mark Foster).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2011/1/21
Y1 - 2011/1/21
N2 - In many age-related and neurological diseases, formerly native proteins aggregate via formation of a partially unfolded intermediate. γS-Crystallin is a highly stable structural protein of the eye lens. In the mouse Opj cataract, a non-conservative F9S mutation in the N-terminal domain core of γS allows the adoption of a native fold but renders the protein susceptible to temperature- and concentration-dependent aggregation, including fibril formation. Hydrogen/deuterium exchange and denaturant unfolding studies of this mutant protein (Opj) have suggested the existence of a partially unfolded intermediate in its aggregation pathway. Here, we used NMR and fluorescence spectroscopy to obtain evidence for this intermediate. In 3.5 M urea, Opj forms a stable and partially unfolded entity that is characterized by an unstructured N-terminal domain and a largely intact C-terminal domain. Under physiologically relevant conditions, Carr-Purcell-Meiboom-Gill T 2-relaxation dispersion experiments showed that the N-terminal domain residues were in conformational exchange with a loosely structured intermediate with a population of 1-2%, which increased with temperature. This provides direct evidence for a model in which proteins of native fold can explore an intermediate state with an increased propensity for formation of aggregates, such as fibrils. For the crystallins, this shows how inherited sequence variants or environmentally induced modifications can destabilize a well-folded protein, allowing the formation of intermediates able to act as nucleation sites for aggregation and the accumulation of light-scattering centers in the cataractous lens.
AB - In many age-related and neurological diseases, formerly native proteins aggregate via formation of a partially unfolded intermediate. γS-Crystallin is a highly stable structural protein of the eye lens. In the mouse Opj cataract, a non-conservative F9S mutation in the N-terminal domain core of γS allows the adoption of a native fold but renders the protein susceptible to temperature- and concentration-dependent aggregation, including fibril formation. Hydrogen/deuterium exchange and denaturant unfolding studies of this mutant protein (Opj) have suggested the existence of a partially unfolded intermediate in its aggregation pathway. Here, we used NMR and fluorescence spectroscopy to obtain evidence for this intermediate. In 3.5 M urea, Opj forms a stable and partially unfolded entity that is characterized by an unstructured N-terminal domain and a largely intact C-terminal domain. Under physiologically relevant conditions, Carr-Purcell-Meiboom-Gill T 2-relaxation dispersion experiments showed that the N-terminal domain residues were in conformational exchange with a loosely structured intermediate with a population of 1-2%, which increased with temperature. This provides direct evidence for a model in which proteins of native fold can explore an intermediate state with an increased propensity for formation of aggregates, such as fibrils. For the crystallins, this shows how inherited sequence variants or environmentally induced modifications can destabilize a well-folded protein, allowing the formation of intermediates able to act as nucleation sites for aggregation and the accumulation of light-scattering centers in the cataractous lens.
KW - cataract
KW - protein unfolding
KW - relaxation dispersion
KW - γS-crystallin
UR - http://www.scopus.com/inward/record.url?scp=78650871880&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650871880&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2010.11.005
DO - 10.1016/j.jmb.2010.11.005
M3 - Article
C2 - 21108948
AN - SCOPUS:78650871880
SN - 0022-2836
VL - 405
SP - 840
EP - 850
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 3
ER -